Fungal infections in humans: the silent crisis

June 1, 2020

This article highlights the growing global threat of fungal infections - exacerbated by rising drug resistance and medical practices - and emphasizes the urgent need for intensified research to develop more effective antifungal strategies.

Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization

March 3, 2016

This article comments on work published by Park et al. (Microbial Cell, 2016), which discovered a number of small molecules capable of modulating Aβ aggregation in a yeast model.